Delivery Order SPE2DB20D9759-SPE2DB25FD5KH
Award Date
1/7/25
Potential Completion Date
1/29/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 firm fixed-price delivery order is for the supply of VisionBlue 0.06% syringes with a 0.5ML capacity.
The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,634.04 firm fixed-price delivery order is for the supply of the pharmaceutical product "VISIONBLUE 0.06% SYRINGE 0.5ML" to support the recurring medical supply needs of military health facilities worldwide.
DMS Pharmaceutical Group holds a significant indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under the DLA's SPE2DB indefinite delivery vehicle, valued at up to $1,634.04 through April 2024. The contract is for the delivery of VISIONBLUE 0.06% Syringe 0.5ML, a pharmaceutical product, to support the medical supply needs of military health facilities. The...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a $3,268.08 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler in Park Ridge, Illinois. The contract is for the delivery of 0.5ML VISIONBLUE 0.06% syringes and has a completion date of May 13, 2024. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA's Medical Supply Chain...
This federal contract award, valued at $2,451.06, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order to provide a specific pharmaceutical product, the VISIONBLUE 0.06% SYRINGE 0.5ML, to support the recurring medical supply needs of military health facilities worldwide.
DMS Pharmaceutical Group holds a significant indefinite...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,634.04, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of June 18, 2024.
The contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML, which is a pharmaceutical product. DMS Pharmaceutical Group Inc. has an Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $3,268.08 award is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML to fulfill the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB24 program. The $3,268.08 award is for the supply of a 0.5mL syringe containing 0.06% VisionBlue solution. The order does not have a set-aside designation.
DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB prime vendor program. The $1,556.52 contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML pharmaceutical products to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $6,536.16, is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML, a specialized pharmaceutical product, with a period of performance through December 6, 2024. This order is issued under a larger Indefinite Delivery Contract (IDC) with a ceiling value of...